This page shows the publications co-authored by Neelam DeSai and Nadine Tung.
Germline genetic testing in breast cancer: Rationale for the testing of all women diagnosed by the age of 60 years and for risk-based testing of those older than 60 years. Cancer. 2021 03 15; 127(6):828-833.
Medical Management of newly diagnosed breast cancer in a BRCA1/2 mutation carrier. Breast J. 2020 08; 26(8):1506-1512.
Intrinsic molecular subtypes of breast cancers categorized as HER2-positive using an alternative chromosome 17 probe assay. Breast Cancer Res. 2018 07 11; 20(1):75.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.